BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8064380)

  • 1. Role of cholecystokinin in the regulation of gastrointestinal motility.
    Grider JR
    J Nutr; 1994 Aug; 124(8 Suppl):1334S-1339S. PubMed ID: 8064380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
    Wang HH; Portincasa P; Wang DQ
    Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: control of gall-bladder motor function.
    Shaffer EA
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():2-8. PubMed ID: 10902995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
    Liddle RA
    Gastroenterol Clin North Am; 1989 Dec; 18(4):735-56. PubMed ID: 2482253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CCK in gallbladder function.
    Schjoldager BT
    Ann N Y Acad Sci; 1994 Mar; 713():207-18. PubMed ID: 8185161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contraction in the gut.
    Grider JR; Makhlouf GM
    Gastroenterology; 1987 Jan; 92(1):175-80. PubMed ID: 3781185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
    Wu CL; Doong ML; Wang PS
    Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholecystokinin and its antagonists: effects on digestive motility].
    Bruley des Varannes S; Cloarec D; Dubois A; Galmiche JP
    Gastroenterol Clin Biol; 1991; 15(10):744-57. PubMed ID: 1816015
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma cholecystokinin, plasma peptide YY and gallbladder motility in patients with slow transit constipation: effect of intestinal stimulation.
    Mollen RM; Hopman WP; Kuijpers HH; Jansen JB
    Digestion; 2000; 62(2-3):185-93. PubMed ID: 11025367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Applicability of CCK receptor antagonists in physiologic and therapeutic studies].
    Heintges T; Niederau C
    Z Gastroenterol; 1992 May; 30(5):337-43. PubMed ID: 1632116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luminal cholecystokinin and gastrin cause gallbladder contraction.
    Brotschi EA; Vaules WA; Kahl EA; Midis NA; Hilbinger CL
    J Surg Res; 1996 May; 62(2):255-9. PubMed ID: 8632648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroendocrine control of gastrointestinal motor activity.
    Torsoli A; Severi C
    J Physiol Paris; 1993; 87(6):367-74. PubMed ID: 7904875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit.
    Degen LP; Peng F; Collet A; Rossi L; Ketterer S; Serrano Y; Larsen F; Beglinger C; Hildebrand P
    Gastroenterology; 2001 Feb; 120(2):361-8. PubMed ID: 11159876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gastric emptying is a physiological action of cholecystokinin.
    Debas HT; Farooq O; Grossman MI
    Gastroenterology; 1975 May; 68(5 Pt 1):1211-7. PubMed ID: 1126597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
    Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of endogenous CCK and CCK1 receptors in colonic motor function.
    Varga G; Bálint A; Burghardt B; D'Amato M
    Br J Pharmacol; 2004 Apr; 141(8):1275-84. PubMed ID: 15100163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vagal nerves and peptides in the control of extrahepatic biliary motility. An experimental study in the cat.
    Dahlstrand C
    Acta Physiol Scand Suppl; 1990; 589():1-52. PubMed ID: 1700577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.